title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Wednesday,20220511T162815,https://www.benzinga.com/markets/options/22/05/27141482/52-weeks-high-and-low-article,INFI,0.006905,Neutral,-0.000674
Stocks That Hit 52-Week Lows On Friday,20220506T160650,https://www.benzinga.com/markets/options/22/05/27050916/52-weeks-high-and-low-article,INFI,0.005467,Neutral,-0.0008
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,INFI,0.00644,Neutral,0.000395
Stocks That Hit 52-Week Lows On Tuesday,20220315T163235,https://www.benzinga.com/news/22/03/26148458/stocks-that-hit-52-week-lows-on-tuesday,INFI,0.00539,Neutral,0.005086
Stocks That Hit 52-Week Lows On Tuesday,20220426T174457,https://www.benzinga.com/markets/options/22/04/26818122/52-weeks-high-and-low-article,INFI,0.00928,Neutral,-0.020749
Stocks That Hit 52-Week Lows On Wednesday,20220427T184104,https://www.benzinga.com/markets/options/22/04/26844275/52-weeks-high-and-low-article,INFI,0.006956,Neutral,-0.007839
51 Biggest Movers From Yesterday,20220331T094126,https://www.benzinga.com/news/22/03/26390922/51-biggest-movers-from-yesterday,INFI,0.071731,Neutral,0.005098
Stocks That Hit 52-Week Lows On Monday,20220314T161153,https://www.benzinga.com/news/22/03/26125409/stocks-that-hit-52-week-lows-on-monday,INFI,0.003772,Neutral,-0.005998
"The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs",20220503T130106,https://www.benzinga.com/general/biotech/22/05/26958446/the-daily-biotech-pulse-fdas-adcomm-for-acadias-pimavanserin-review-issues-for-speros-tebipenem-a,INFI,0.093507,Neutral,-0.000393
"Earnings Scheduled For May 3, 2022",20220503T085235,https://www.benzinga.com/news/earnings/22/05/26953640/earnings-scheduled-for-may-3-2022,INFI,0.01558,Neutral,-0.088514
"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim",20230803T210100,https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html,INFI,0.02074,Neutral,-0.002722
99 Biggest Movers From Yesterday,20220512T082956,https://www.benzinga.com/news/22/05/27156577/99-biggest-movers-from-yesterday,INFI,0.063655,Neutral,-0.012145
Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors - Alkermes  ( NASDAQ:ALKS ) ,20230613T110000,https://www.benzinga.com/pressreleases/23/06/n32831446/alkermes-issues-letter-to-shareholders-highlighting-skills-and-experience-of-refreshed-board-of-di,INFI,0.009551,Somewhat-Bearish,-0.177696
70 Biggest Movers From Friday,20220531T091540,https://www.benzinga.com/news/22/05/27467950/70-biggest-movers-from-friday,INFI,0.056527,Neutral,0.002929
"Why EMCORE Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Amyris  ( NASDAQ:AMRS ) , Akanda  ( NASDAQ:AKAN ) ",20230809T121536,https://www.benzinga.com/news/23/08/33664102/why-emcore-shares-are-trading-higher-by-17-here-are-20-stocks-moving-premarket,INFI,0.18967,Somewhat-Bearish,-0.260734
Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028 | DelveInsight,20230821T210100,https://www.prnewswire.com/news-releases/medical-second-opinion-global-market-to-register-stunning-growth-at-a-cagr-of-17-by-2028--delveinsight-301905294.html,INFI,0.024347,Neutral,-0.03954
"Why Cano Health Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket - Arcellx  ( NASDAQ:ACLX ) , Biofrontera  ( NASDAQ:BFRI ) ",20230620T121028,https://www.benzinga.com/news/23/06/32920824/why-cano-health-shares-are-trading-higher-by-14-here-are-20-stocks-moving-premarket,INFI,0.137671,Somewhat-Bearish,-0.213433
12 Health Care Stocks Moving In Wednesday's Intraday Session,20220330T175718,https://www.benzinga.com/intraday-update/22/03/26380533/12-health-care-stocks-moving-in-wednesdays-intraday-session,INFI,0.06645,Neutral,0.003727
"Triple-Negative Breast Cancer Market to Accelerate Substantially During the Forecast Period  ( 2023-2032 ) , Examines DelveInsight | Key Companies to Watch - Roche, AbbVie, AstraZeneca, BeiGene, GlaxoSmithKline, Genentech, Eli Lilly, Novartis",20230906T210100,https://www.prnewswire.com/news-releases/triple-negative-breast-cancer-market-to-accelerate-substantially-during-the-forecast-period-20232032-examines-delveinsight--key-companies-to-watch---roche-abbvie-astrazeneca-beigene-glaxosmithkline-genentech-eli-lilly--301918858.html,INFI,0.06741,Neutral,0.006065
